Given the abundance of growing healthcare concerns (chronic diseases, generic disease, and more), the healthcare and pharmaceutical industry has witnessed huge rise in the past few years, while COVID-19 prevalence has boosted it. Low cost of production and R&D has increased efficiency of Indian pharma companies, leading to competitive exports. Today, India is a major exporter of pharmaceuticals, exporting Indian pharmaceuticals to over 200 countries. India supplies over 50 percent of Africa's pharma requirement for generics, including 40 percent of generic demands in the US and 25 percent of all medicine in the UK. India also accounts for 60 percent of global vaccine supplies, and is a leading supplier of DPT, BCG and Measles vaccines. Also, 70 percent of WHO’s vaccines (as per the essential Immunization schedule) are sourced from India. The domestic pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units in the country. While the pharmaceutical industry in India was valued at $50 billion recently, it is expected to reach $65 billion by 2024 and to $120 billion by 2030. Comprehending the burgeoning pharmaceutical demands of the geographies, including the renowned pharma companies, there are many startups backing the pharmaceutical industry in India today leveraging their high-quality pharma products.

Pharma Industry Outlook in this issue presents a list of ‘Top 10...